LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PHA-665752 | 3.33 | uM | LJP5 | 2 | F14 | 72 | hr | 1401 | 3931 | 4213 | 0.9330 | 0.9145 |
| SK-BR-3 | PHA-665752 | 3.33 | uM | LJP5 | 3 | F14 | 72 | hr | 1401 | 4127 | 4545 | 0.9079 | 0.8893 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 1 | F13 | 72 | hr | 1401 | 670 | 3978 | 0.1684 | -0.3876 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 2 | F13 | 72 | hr | 1401 | 1095 | 4213 | 0.2599 | -0.1440 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 3 | F13 | 72 | hr | 1401 | 870 | 4545 | 0.1914 | -0.2449 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 1 | I18 | 72 | hr | 1401 | 3571 | 4139 | 0.8628 | 0.8197 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 2 | I18 | 72 | hr | 1401 | 3592 | 4095 | 0.8771 | 0.8374 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 3 | I18 | 72 | hr | 1401 | 3916 | 4272 | 0.9166 | 0.8946 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 1 | I17 | 72 | hr | 1401 | 2378 | 4139 | 0.5745 | 0.4027 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 2 | I17 | 72 | hr | 1401 | 2336 | 4095 | 0.5704 | 0.3913 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 3 | I17 | 72 | hr | 1401 | 3099 | 4272 | 0.7254 | 0.6380 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 1 | I16 | 72 | hr | 1401 | 1591 | 4139 | 0.3844 | 0.0845 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 2 | I16 | 72 | hr | 1401 | 1825 | 4095 | 0.4456 | 0.1861 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 3 | I16 | 72 | hr | 1401 | 1918 | 4272 | 0.4489 | 0.2154 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 1 | I15 | 72 | hr | 1401 | 1401 | 4139 | 0.3385 | -0.0002 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 2 | I15 | 72 | hr | 1401 | 1552 | 4095 | 0.3790 | 0.0681 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 3 | I15 | 72 | hr | 1401 | 1565 | 4272 | 0.3663 | 0.0710 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 1 | I14 | 72 | hr | 1401 | 1243 | 4139 | 0.3003 | -0.0740 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 2 | I14 | 72 | hr | 1401 | 1561 | 4095 | 0.3812 | 0.0721 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 3 | I14 | 72 | hr | 1401 | 1649 | 4272 | 0.3860 | 0.1064 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 1 | I13 | 72 | hr | 1401 | 1301 | 4139 | 0.3143 | -0.0465 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 2 | I13 | 72 | hr | 1401 | 1397 | 4095 | 0.3411 | -0.0021 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 3 | I13 | 72 | hr | 1401 | 1347 | 4272 | 0.3153 | -0.0244 |
| SK-BR-3 | Dovitinib | 0.04 | uM | LJP5 | 1 | E24 | 72 | hr | 1401 | 3605 | 3978 | 0.9061 | 0.8732 |
| SK-BR-3 | Dovitinib | 0.04 | uM | LJP5 | 2 | E24 | 72 | hr | 1401 | 3821 | 4213 | 0.9069 | 0.8806 |